These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2564435)

  • 1. Neuroleptic-resistant schizophrenics.
    Murray JB
    J Psychol; 1989 Jan; 123(1):69-78. PubMed ID: 2564435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to neuroleptic drugs as a device for classifying schizophrenia.
    Brown WA; Herz LR
    Schizophr Bull; 1989; 15(1):123-9. PubMed ID: 2566199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between neuroleptic dose and positive and negative symptoms.
    Johnson PB; Ramirez PM; Opler LA; Malgady R
    Psychol Rep; 1994 Apr; 74(2):481-2. PubMed ID: 7910976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia].
    Lisoprawski A
    Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroquel in a resistant schizophrenic with negative and positive symptoms].
    Reznik I; Benatov R; Sirota P
    Harefuah; 1996 May; 130(10):675-7, 727. PubMed ID: 8794656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
    Schooler NR
    Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenic thinking and neuroleptic dosage.
    Puente AE; Andersson C
    J Clin Psychol; 1987 Mar; 43(2):189-97. PubMed ID: 2883201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Profile of the action of neuroleptics in deficit schizophrenia].
    Vanelle JM
    Encephale; 1996 Jun; 22 Spec No 2():33-9. PubMed ID: 8767040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cortical atrophy in MRI, mental status and neuroleptic treatment effect in schizophrenia].
    Jarema M; Choma M; Kozłowski P; Poniatowska R; Krawczyk R
    Psychiatr Pol; 1997; 31(5):547-57. PubMed ID: 9547181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Principles of chemotherapy of paranoid schizophrenia].
    Vanelle JM; Loloum T
    Encephale; 1991; 17(4):235-40. PubMed ID: 1683623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic, pharmacologic, and psychosocial factors influencing response to neuroleptics.
    Kane JM
    Psychopharmacol Bull; 1992; 28(3):227-9. PubMed ID: 1362275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compliance in therapy of schizophrenic patients with neuroleptics--an overview].
    Mayer C; Soyka M
    Fortschr Neurol Psychiatr; 1992 Jun; 60(6):217-22. PubMed ID: 1353747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.